CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors.

ABSTRACT:

SUBMITTER: Moertel C 

PROVIDER: S-EPMC9997597 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature